Skip to main content
. 2015 Aug 14;10(8):e0135599. doi: 10.1371/journal.pone.0135599

Fig 4. Fluoropyrimidine subgroup analysis for PFS–combining EGFR-I with oxaliplatin-based chemotherapy.

Fig 4